Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|18|3334-3342

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.18, 2013-09, pp. : 3334-3342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 39-47

Karger

Access to resources Recommend Favorite

Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 637-643

Karger

Access to resources Recommend Favorite

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite

Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 148-153

Karger

Access to resources Recommend Favorite

Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 184-191

Karger

Access to resources Recommend Favorite